THOMAS PHD ADAMS
CIK 1234366 · Executive Chairman · last filed 2021-06-14
THOMAS PHD ADAMS is an Executive Chairman who has filed 51 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for CRDF, was dated Jun 14, 2021. Across all open-market trades the lifetime net is −$137.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$29.1K
7
51
-$137.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Executive Chairman | 18,875 | $1.54 | $29.1K | $20.0K | 3 | 2021-06-14 |
| HEPA | Director | — | $0.08 | — | $0 | 4 | 2021-05-20 |
| Cardiff Oncology, Inc. (TROV) Delisted | Chief Executive Officer | 351,959 | — | — | $0 | 5 | 2019-06-24 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Director | 100,023 | — | — | $0 | 3 | 2018-07-06 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Director | 330,686 | — | — | -$157.2K | 7 | 2017-01-05 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Director | — | — | — | $0 | 7 | 2016-06-29 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | — | $6.22 | — | $0 | 2 | 2008-05-23 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-14 | CRDF | Other (J) | — | $0 | EDGAR |
| 2021-05-20 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-08-21 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2020-05-18 | CRDF | Buy (P) | +13,986 | $20.0K | EDGAR |
| 2020-04-07 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2019-07-25 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-06 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Mixed | +72,238 | $50.0K | EDGAR |
| 2018-06-19 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |